-+ 0.00%
-+ 0.00%
-+ 0.00%

HERON THERAPEUTICS: ADJUSTED EBITDA GUIDANCE RAISED TO A RANGE OF $4 MLN - $12 MLN FOR FY 2025

Reuters·05/06/2025 11:45:04

Please log in to view news